Drug Resistance in Mycobacterium Leprae in the Context of Zero Leprosy
- PMID: 34934713
- PMCID: PMC8653743
- DOI: 10.4103/idoj.idoj_599_21
Drug Resistance in Mycobacterium Leprae in the Context of Zero Leprosy
References
-
- Irgens LM. The discovery of the leprosy bacillus. Tidsskr Nor Laegeforen. 2002;122:708–9. - PubMed
-
- Han XY, Seo YSH, Sizer KC, Schoberle T, May GS, Spencer JS, et al. A new Mycobacterium species causing diffuse lepromatous leprosy. Am J Clin Path. 2008;130:856–64. - PubMed
-
- Zhu YI, Stiller MJ. Dapsone and sulfones in dermatology: Overview and update. J Am Acad Dermatol. 2001;45:42034. - PubMed
-
- Pearson J, Rees R, Waters M. Sulfone resistance in leprosy.A review of 100 proven clinical cases. Lancet. 1975;2:69–72. - PubMed
-
- Pearson JM, Haile GS, Rees RJ. Primary dapsone-resistant leprosy. Lepr Rev. 1977;48:129–32. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
